Cigna prices $4.5 billion in senior notes, uses proceeds to repay $2.0 billion loan
Cigna completed a $4.5 billion sale of four series of senior notes maturing from 2030 to 2056. The company said it will use most of the proceeds to repay $2.0 billion of loans under a term loan that funded a strategic investment in another company.
Key points
- Four note series totaling $4.5 billion: $1.0 billion due 2030, $1.25 billion due 2032, $1.5 billion due 2036, and $750 million due 2056
- Proceeds to repay $2.0 billion outstanding under the Term Loan Agreement dated August 5, 2025; remainder for general corporate purposes
- Interest rates range from 4.500% to 6.000%, with the 2056 notes carrying the highest rate
The filing
Written by AI on Nov 8, 2026, 1:21 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 04, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.